$249.82 1.77 (0.70%)
11:04 EDT AMGN Stock Quote Delayed 30 Minutes
Previous Close $250.00
Market Cap 165.31B
PE Ratio 79.31
Volume (Avg. Vol.) 383,355
Day's Range 249.51 - 253.83
52-Week Range 173.12 - 264.97
Dividend & Yield 5.28 (2.11%)
AMGN Stock Predictions, Articles, and Amgen News
- From InvestorPlace
- From the Web
These four strong California stocks deserve your attention and further due diligence to be included in long-term portfolios.
There is ridiculously big upside potential for Chinese biotech stocks in the next decade. The spread of the pandemic has only strengthened the case.
As the world and the markets continue to grapple with the effects of the novel coronavirus outbreak, these innovative healthcare stocks to buy look poised for success.
These healthcare stocks are worth selling now as Sanders rises in the polls and given his stance that prices should be cut in half.
Matt McCall predicts that 2020 will be a better year for U.S. cannabis stocks. He's also calling for a big rally in bitcoin.
Goldman Sachs analysts came out with three conviction buys on Monday. Here's what else happened in the stock market today.
The year-end success of the healthcare sector has led to several strong stocks to buy. Here are three of the best healthcare stocks to buy.
Folks who haven’t been paying attention to the absolutely huge potential happening in biotech stocks right now -- both in the U.S. and other parts of the world -- have been put on notice.
The biggest risk to Amgen stock comes from health reform that might limit the number of drugs insurers pay for, creating price competition.
Biotech stocks overall are holding up fairly well amid recent market volatility. Look at which four biotech stocks to buy have staying power.
Amgen's purchase of Celgenes blockbuster psoriasis drug, Otezla is likely to strengthen its position in the immunology space and boost Amgen stock.
Trade talks gave a lift to stocks, while Johnson & Johnson will be in focus after the close. Here's what happened in the stock market today.
Netflix, Amgen, Bristol-Myers Squibb, Aurora Cannabis and Foot Locker are our top stock trades for Tuesday. Here's how to trade them.
Celgene news for Thursday about it selling Otezla has CELG stock on the rise as it moves forward with the Bristol-Myers Squibb merger.
Options trading was buzzing on Tuesday, with Amgen, American Airlines and Apple all making notable moves. Here are the metrics that matter moving forward.
Matt McCall is extremely bullish on China and the big opportunities in several sectors, but Chinese biotech stocks top his list.
Q2 earnings season rolls on and Wall Street tries to not act disappointed by the early end to the latest round of U.S.-China trade talks. Thus, individual stock price action is uneven with all the focus going to a handful of names posting solid results.
Navellier RatingsPowered by Portfolio Grader